Outcome of Thromboembolic Events and Its Influence on Survival Time of Advanced NSCLC Patients Treated with Antiangiogenic Therapy

BACKGROUND: Antiangiogenetic therapy and lung cancer, per se, are associated with an increased risk of thromboembolic events (TE). We aim to evaluate the pattern and outcome of TE as well as its influence on survival time of advanced non-small cell lung cancer (NSCLC) patients receiving antiangiogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Wei-Fan, Liao, Pei-Ya, Hsu, Yu-Wei, Huang, Yen-Hsiang, Hsu, Kuo-Hsuan, Tseng, Jeng-Sen, Chang, Gee-Chen, Yang, Tsung-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637185/
https://www.ncbi.nlm.nih.gov/pubmed/37953889
http://dx.doi.org/10.2147/CMAR.S430868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637185/
https://www.ncbi.nlm.nih.gov/pubmed/37953889
http://dx.doi.org/10.2147/CMAR.S430868

Ejemplares similares